Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Zolmitriptan Tablets

Approval Number

国药准字H20051234

Company海南海神同洲制药有限公司

Registration Date

April 7, 2020

Drug Information

Generic Name

佐米曲普坦片

Trade Name

枢复来

Dosage Form

片剂

Strength

2.5mg

Drug Type

化学药品

Registration Date

April 7, 2020

Company Information

Applicant Company

Company Name海南海神同洲制药有限公司

Company Address

海南省海口市国家高新区药谷工业园药谷二路6号

Manufacturing Company

Company Name海南益尔药业有限公司

Company Address

海口市美兰区灵山镇顺达路4号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy